Industry groups call for changes to FDA’s guidance on use-related risk analyses
Regulatory NewsJoanne S. Eglovitch
Combination productsCombination products/companion diagnosticsGuidanceProduct developmentRegulatory Intelligence/PolicyUnited StatesRegulatory NewsJoanne S. EglovitchCombination productsCombination products/companion diagnosticsGuidanceProduct developmentRegulatory Intelligence/PolicyUnited States